John Wilkinson, of the MHRA becomes new Chair of the GMDN Agency, overseeing the de facto global standard for naming medical devices.
The Global Medical Device Nomenclature Agency is pleased to announce that John Wilkinson, OBE, the Director of Devices at the UK’s MHRA (the Medicines and Healthcare products Regulatory Agency) has become the new Chair of its board of Trustees.
The five-person board oversees the governance and strategic direction of the GMDN Agency, which oversees the operation of the General Medical Device Nomenclature, the de facto global standard for identifying the world’s millions of medical devices.
John, who had previously been one of the five members of the Agency’s Board of Trustees since April 2017, succeeds Janet Trunzo who has been Chair for 10 years.
John Wilkinson said: “I am becoming Chair at an important time because of the now widespread use of the GMDN by manufacturers and others around the world as the de facto standard for accurately describing and categorising the millions of medical devices sold each year.
“My objectives as Chair are to enable the Agency to realise the full potential for GMDN to deliver a consistent and globally utilised tool for the exchange and analysis of product category performance data. This offers huge potential benefits, not least through enabling the more rapid detection of products that are unsafe, whether individually or as a category, through the GMDN providing consistent product data to aid epidemiological studies.”
John shares his views about the GMDN in his recent video https://www.gmdnagency.org/Services/Using
Janet Trunzo, who will continue as one of the five-person Board of Trustees of the GMDN Agency said: “I am particularly pleased with having helped steer the recent introduction of the free provision of the GMDN data to lots of new users, which within a matter of weeks has already increased the number of subscribers by 1,300 to a total of over 4,000 members.”
“Other important achievements by the GMDN Agency during my tenure as Chair include strengthening our staff resources and business processes to create a customer responsive and sustainable organisation.”
Mark Wasmuth, the CEO of the GMDN Agency, said: “I would like to personally thank Janet for her professional guidance she has given the Agency during her time as Chair, laying the foundations for an exciting future and look forward to her continued participation as a Board member.”
Background on Janet Trunzo
Janet E. Trunzo is Senior Advisor to the President and Senior Executive Vice President, Technology and Regulatory Affairs, for the Advanced Medical Technology Association (AdvaMed) and leads a team of regulatory experts.
During her tenure at AdvaMed, she has focused on the passage of the Medical Device User Fee and Modernization Act of 2002 and subsequent updates. She also concentrates on global regulatory harmonisation and representing the U.S. device industry on the Global Harmonization Task Force. She also chairs the Regulatory Committee for the Global Medical Technology Alliance.
Previously Janet held positions at Hybritech, Inc., a medical device and diagnostics manufacturer, and Scripps Clinic and Research Foundation, a hospital, diagnostic clinic and research institute.
Background on John Wilkinson, OBE
Prior to joining the MHRA, John was Chief Executive of Eucomed, the European medical technology industry association.
His earlier experience included the role of Director General of the Association of British Healthcare Industries and a number of roles in the medical devices industry, both in the UK and the USA, with Becton Dickinson and the BOC Group. These were followed by a period as Chief Executive of an early stage medical imaging company.
John holds a first degree in Zoology from the University of Aberdeen and an MBA from the University of Warwick.
He was awarded an OBE for services to the medical devices industry in the 2010 New Year’s honours list.